Published in N Engl J Med on April 29, 1982
Efficacy and Safety Study on Agilis NxT Introducer in AF Patients (AGILIS) | NCT00469638
Catheter Ablation vs. Medical Therapy in Congested Hearts With AF (CATCH-AF) | NCT02686749
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract (1997) 3.29
Screening for atrial fibrillation in primary care. Heart (1998) 3.02
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart (2001) 2.78
Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation (2008) 2.72
Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice. BMJ (1996) 2.57
Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg (1997) 2.50
Determinants of successful direct current cardioversion for atrial fibrillation and flutter: the importance of rapid referral. Br J Gen Pract (2000) 2.04
Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80
The prognosis of hospital-referred transient ischaemic attacks. J Neurol Neurosurg Psychiatry (1991) 1.73
Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol (2000) 1.65
Natural history of secundum atrial septal defect in adults after medical or surgical treatment: a historical prospective study. Br Heart J (1994) 1.59
Alcohol consumption and risk of incident atrial fibrillation in women. JAMA (2008) 1.55
Predictors of early mortality in implantable cardioverter-defibrillator recipients. Europace (2009) 1.55
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Circ Arrhythm Electrophysiol (2010) 1.51
Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care (2009) 1.49
Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation. Nat Med (2010) 1.49
Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci (2005) 1.47
Common causes of cardiac emboli--left ventricular thrombi and atrial fibrillation. West J Med (1989) 1.42
ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation. BMJ (1995) 1.39
Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol (2014) 1.39
Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin (2009) 1.38
P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol (2009) 1.35
Aortic saddle embolus. A twenty-year experience. Ann Surg (1983) 1.30
64-MDCT showed the thrombus in the pulmonary vein of the patient with angina pectoris. BMJ Case Rep (2012) 1.30
Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol (2011) 1.26
Predictors of atrial fibrillation following coronary artery bypass grafting. Clin Med Insights Cardiol (2011) 1.22
Cardioversion in Non-Valvular Atrial Fibrillation. Dtsch Arztebl Int (2015) 1.18
Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial. Eur J Clin Pharmacol (2003) 1.18
Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J (2011) 1.17
Stroke and atrial fibrillation: is stroke prevention treatment appropriate beforehand? SAFE I Study Investigators. Heart (1999) 1.16
Atrial fibrillation as a predictive factor for severe stroke and early death in 15,831 patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry (2005) 1.14
Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessels (2012) 1.13
Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol (2010) 1.11
Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels. Naunyn Schmiedebergs Arch Pharmacol (2004) 1.11
Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly. Eur J Epidemiol (2001) 1.10
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One (2011) 1.10
Use of 24 h ambulatory ECG recordings in the assessment of new chemical entities in healthy volunteers. Br J Clin Pharmacol (1995) 1.07
Non-rheumatic atrial fibrillation: warfarin or aspirin for all? Br Heart J (1992) 1.07
The role of echocardiography in managing cardiac emboli. West J Med (1989) 1.06
Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc Res (2009) 1.05
Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat. Br J Clin Pharmacol (2005) 1.03
Benefits of dual chamber pacing in sick sinus syndrome. Br Heart J (1988) 1.02
Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg (2013) 1.00
Heart failure and atrial fibrillation: current concepts and controversies. Heart (1997) 0.98
Recent developments in atrial fibrillation. BMJ (2005) 0.97
Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation. Br Heart J (1990) 0.97
Long-term risk of atrial fibrillation with symptomatic gastroesophageal reflux disease and esophagitis. Am J Cardiol (2008) 0.97
Thyrotoxic atrial fibrillation: an underdiagnosed condition? Br Med J (Clin Res Ed) (1982) 0.96
Why is the outcome of transient ischaemic attacks different in different groups of patients? BMJ (1993) 0.96
Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health (1998) 0.95
Comparison of the effectiveness of intravenous diltiazem and metoprolol in the management of rapid ventricular rate in atrial fibrillation. Emerg Med J (2005) 0.95
Monogenic atrial fibrillation as pathophysiological paradigms. Cardiovasc Res (2010) 0.94
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart (2006) 0.93
Interleukin-6 promoter polymorphisms and susceptibility to atrial fibrillation in elderly Han Chinese patients with essential hypertension. J Interferon Cytokine Res (2012) 0.92
Diagnostic value of thyrotrophin releasing hormone tests in elderly patients with atrial fibrillation. Br Med J (Clin Res Ed) (1985) 0.91
The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Trans Am Clin Climatol Assoc (2004) 0.91
Differential impact of race and risk factors on incidence of atrial fibrillation. Am Heart J (2011) 0.91
Atrial fibrillation: to map or not to map? Neth Heart J (2014) 0.90
Age-related atrial fibrosis. Age (Dordr) (2008) 0.90
Surgery for atrial fibrillation. Nat Rev Cardiol (2009) 0.90
Atrial fibrillation pearls and perils of management. West J Med (1996) 0.89
Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis. Int J Cardiovasc Imaging (2013) 0.88
LKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process. J Am Heart Assoc (2015) 0.88
Development and application of a longitudinal electrocardiogram repository: the Framingham Heart Study. J Electrocardiol (2012) 0.88
Right atrial lesions do not improve the efficacy of a complete left atrial lesion set in the surgical treatment of atrial fibrillation, but they do increase procedural morbidity. J Thorac Cardiovasc Surg (2013) 0.88
Current ablation strategies for persistent and long-standing persistent atrial fibrillation. Cardiol Res Pract (2011) 0.88
Role of Left Ventricular Diastolic Dysfunction in Predicting Atrial Fibrillation Recurrence after Successful Electrical Cardioversion. J Atr Fibrillation (2012) 0.87
Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias. Heart (1998) 0.87
Fibrosis in Atrial Fibrillation - Role of Reactive Species and MPO. Front Physiol (2012) 0.87
A Novel Transgenic Mouse Model of Cardiac Hypertrophy and Atrial Fibrillation. J Atr Fibrillation (2012) 0.86
Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis. Rheumatol Int (2004) 0.86
Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension. Clinics (Sao Paulo) (2013) 0.86
Genetic polymorphisms in ZFHX3 are associated with atrial fibrillation in a Chinese Han population. PLoS One (2014) 0.86
Targets and endpoints in ablation therapy for atrial fibrillation in the light of pathophysiological mechanisms. J Interv Card Electrophysiol (2006) 0.86
The symbiosis of contact force catheter use for hybrid ablation for atrial fibrillation. Neth Heart J (2015) 0.85
Atrial fibrillation in a tertiary care institute - a prospective study. Indian Heart J (2012) 0.84
Methods for the development and assessment of atrial fibrillation and heart failure dog models. J Geriatr Cardiol (2011) 0.84
Atrial fibrillation: effects beyond the atrium? Cardiovasc Res (2015) 0.84
Comparative aspects of the dual role of the human atrioventricular node. Br Heart J (1986) 0.84
Present concepts in management of atrial fibrillation: From drug therapy to ablation. World J Cardiol (2009) 0.84
Experimental and clinical AF mechanisms: bridging the divide. J Interv Card Electrophysiol (2003) 0.84
When atrial fibrillation occurs with pulmonary embolism, is it the chicken or the egg? CMAJ (1999) 0.84
Early experience using a left atrial appendage occlusion device in patients with atrial fibrillation. Yonsei Med J (2012) 0.84
Midterm results of left atrial bipolar radiofrequency ablation combined with a mitral valve procedure in persistent atrial fibrillation. Cardiovasc J Afr (2010) 0.84
Surgical Ablation of Atrial Fibrillation Using Energy Sources. Braz J Cardiovasc Surg (2015) 0.83
Esophageal cancer presenting with atrial fibrillation: a case report. J Med Case Rep (2008) 0.83
Left atrial enlargement as a predictor of recurrences in lone paroxysmal atrial fibrillation. Can J Cardiol (2007) 0.83
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol (2015) 0.83
AdipoR1/APPL1 potentiates the protective effects of globular adiponectin on angiotensin II-induced cardiac hypertrophy and fibrosis in neonatal rat atrial myocytes and fibroblasts. PLoS One (2014) 0.83
A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation. Heart Rhythm (2014) 0.82
Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol (2004) 0.82
Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis. Kidney Int (2015) 0.82
Plasma B-type natriuretic peptide as a predictor of cardiovascular events in subjects with atrial fibrillation: a community-based study. PLoS One (2013) 0.82
Non-pharmacological treatment of atrial fibrillation. Indian Pacing Electrophysiol J (2002) 0.81
A functional single-nucleotide polymorphism in interleukin-6 promoter is associated with p wave dispersion in hypertensive subjects with atrial fibrillation. Int J Clin Exp Med (2014) 0.81
Atrial remodeling: evolving concepts. Indian Pacing Electrophysiol J (2003) 0.81
Postoperative Atrial Fibrillation following Open Cardiac Surgery: Predisposing Factors and Complications. J Cardiovasc Thorac Res (2013) 0.81
Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol (2013) 0.81
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation (1983) 12.63
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Evaluation of chest pain in the emergency department. Ann Intern Med (1994) 7.12
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA (1996) 4.40
Effects of walking on mortality among nonsmoking retired men. N Engl J Med (1998) 4.33
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Maintaining mobility in late life. I. Demographic characteristics and chronic conditions. Am J Epidemiol (1993) 3.74
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med (1967) 3.65
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Frequency and characteristics of silent dementia among elderly Japanese-American men. The Honolulu-Asia Aging Study. JAMA (1997) 3.55
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
The dynamics of alcohol and marijuana initiation: patterns and predictors of first use in adolescence. Am J Public Health (2000) 3.11
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA (2000) 2.89
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Developmental risk factors for youth violence. J Adolesc Health (2000) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis (1989) 2.65
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
beta(2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: the honolulu heart program. Stroke (2001) 2.60
Childhood and adolescent predictors of alcohol abuse and dependence in young adulthood. J Stud Alcohol (2001) 2.59
The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA (1988) 2.59
Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial. Am Heart J (1986) 2.55
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Relation of weight change to changes in atherogenic traits: the Framingham Study. J Chronic Dis (1974) 2.48